Pulmonary Infections in Immunocompromised Hosts: Clinical

Area of Science:

• Infectious Diseases
• Pulmonology
• Immunology

Background:

• Pulmonary infections pose significant mortality, morbidity, and cost burdens in immunocompromised individuals.
• Epidemiology is shifting due to new immunosuppressive and prophylactic strategies.
• Host factors, clinical symptoms, and radiographic findings are also evolving.

Purpose of the Study:

• To review emerging trends in the epidemiology of pulmonary infections in immunocompromised patients.
• To discuss updated clinical findings and diagnostic approaches.
• To examine differential diagnoses, including malignancies and treatment toxicities.

Main Methods:

• Review of current literature on pulmonary infections in immunocompromised populations.
• Analysis of changing trends in immunosuppression and prophylaxis.
• Evaluation of advancements in diagnostic microbiology, including non-culture methods.
• Assessment of chest imaging's role in initial workup.

Main Results:

• Epidemiology of pulmonary infections in immunocompromised hosts is dynamic.
• Clinical presentations and radiographic patterns show evolving characteristics.
• Non-culture diagnostic methods enhance pathogen identification.
• Differential diagnoses encompass malignancies and treatment-related toxicities.

Conclusions:

• Understanding evolving trends in pulmonary infections is crucial for immunocompromised patients.
• Integrated approaches combining clinical, imaging, and advanced microbiological diagnostics are essential.
• Distinguishing infections from other conditions like malignancies is critical for effective management.